Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H19N4O2.Cl |
| Molecular Weight | 358.822 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].CC(CC1=CC=CC=C1)[N+]2=NOC(NC(=O)NC3=CC=CC=C3)=C2
InChI
InChIKey=XRBSKWQSGQWVKG-UHFFFAOYSA-N
InChI=1S/C18H18N4O2.ClH/c1-14(12-15-8-4-2-5-9-15)22-13-17(24-21-22)20-18(23)19-16-10-6-3-7-11-16;/h2-11,13-14H,12H2,1H3,(H-,19,20,21,23);1H
Mesocarb (sydnocarb or 3-(beta-phenylisopropyl)-N-phenylcarbamoylsydnonimine) is a psychomotor stimulant N-alkylated amphetamine derivative. Mesocarb is a selective inhibitor of dopamine uptake, it potently blocks dopamine transporter. It is very likely that mesocarb is being used by drug addicts. Mesocarb is included in the World Anti-Doping Agency’s list of substances and methods that are prohibited in sports. It is used in Russia for the treatment of a variety of neuropsychiatric comorbidities.
Approval Year
Sample Use Guides
The drug is administered orally, before meals, 1-2 times a day in the first half of the day. Adults: initial dose of 0.005 g / day; if necessary - up to 0,015-0,05 g / day; maintenance dose - 0.005-0.01 g / day, the highest single dose - 0.075 g, daily - 0.15 g
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9TH184G0MY
Created by
admin on Sat Dec 16 10:20:28 GMT 2023 , Edited by admin on Sat Dec 16 10:20:28 GMT 2023
|
PRIMARY | |||
|
112500475
Created by
admin on Sat Dec 16 10:20:28 GMT 2023 , Edited by admin on Sat Dec 16 10:20:28 GMT 2023
|
PRIMARY | |||
|
117015-72-2
Created by
admin on Sat Dec 16 10:20:28 GMT 2023 , Edited by admin on Sat Dec 16 10:20:28 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
